These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 31270082

  • 21. FcγRIIa and FcγRIIIa genetic polymorphisms in a group of pediatric immune thrombocytopenic purpura in Egypt.
    Eyada TK, Farawela HM, Khorshied MM, Shaheen IA, Selim NM, Khalifa IA.
    Blood Coagul Fibrinolysis; 2012 Jan; 23(1):64-8. PubMed ID: 22123287
    [Abstract] [Full Text] [Related]

  • 22. Relation of interleukin-10 Promoter Polymorphisms to Adult Chronic Immune Thrombocytopenic Purpura in a Cohort of Egyptian Population.
    El Ghannam D, Fawzy IM, Azmy E, Hakim H, Eid I.
    Immunol Invest; 2015 Jan; 44(7):616-26. PubMed ID: 26436850
    [Abstract] [Full Text] [Related]

  • 23. STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia.
    Chen Z, Guo Z, Ma J, Liu F, Gao C, Liu S, Wang A, Wu R.
    Autoimmunity; 2015 Jan; 48(5):305-12. PubMed ID: 25707685
    [Abstract] [Full Text] [Related]

  • 24. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
    Higashide Y, Hori T, Yoto Y, Kabutoya H, Honjo S, Sakai Y, Nojima M, Yoda M, Yamamoto M, Tsutsumi H.
    Pediatr Int; 2018 Apr; 60(4):357-361. PubMed ID: 29297955
    [Abstract] [Full Text] [Related]

  • 25. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice.
    Huang HS, Sun DS, Lien TS, Chang HH.
    Blood; 2010 Dec 02; 116(23):5002-9. PubMed ID: 20699442
    [Abstract] [Full Text] [Related]

  • 26. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.
    Morimoto Y, Yoshida N, Kawashima N, Matsumoto K, Kato K.
    Int J Hematol; 2014 Dec 02; 99(5):597-602. PubMed ID: 24573984
    [Abstract] [Full Text] [Related]

  • 27. Clinical features and major histocompatibility complex genes as potential susceptibility factors in pediatric immune thrombocytopenia.
    Ho WL, Lu MY, Hu FC, Lee CC, Huang LM, Jou ST, Lin DT, Lin KH.
    J Formos Med Assoc; 2012 Jul 02; 111(7):370-9. PubMed ID: 22817814
    [Abstract] [Full Text] [Related]

  • 28. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS, Mokhtar GM, El-Laboudy MA, Khalifa AS.
    Acta Haematol; 2006 Jul 02; 115(1-2):46-52. PubMed ID: 16424649
    [Abstract] [Full Text] [Related]

  • 29. Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.
    Chotsampancharoen T, Sripornsawan P, Duangchoo S, Wongchanchailert M, McNeil E.
    Pediatr Blood Cancer; 2017 Jan 02; 64(1):128-134. PubMed ID: 27571705
    [Abstract] [Full Text] [Related]

  • 30. Treatment of immune thrombocytopenic purpura in children : current concepts.
    Shad AT, Gonzalez CE, Sandler SG.
    Paediatr Drugs; 2005 Jan 02; 7(5):325-36. PubMed ID: 16220997
    [Abstract] [Full Text] [Related]

  • 31. Mechanistic properties of intravenous immunoglobulin in murine immune thrombocytopenia: support for FcγRIIB falls by the wayside.
    Crow AR, Lazarus AH.
    Semin Hematol; 2016 Apr 02; 53 Suppl 1():S20-2. PubMed ID: 27312158
    [Abstract] [Full Text] [Related]

  • 32. Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.
    Sehgal K, Guo X, Koduru S, Shah A, Lin A, Yan X, Dhodapkar KM.
    Sci Transl Med; 2013 Jul 10; 5(193):193ra89. PubMed ID: 23843450
    [Abstract] [Full Text] [Related]

  • 33. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
    Leontyev D, Katsman Y, Ma XZ, Miescher S, Käsermann F, Branch DR.
    Transfusion; 2012 Aug 10; 52(8):1799-805. PubMed ID: 22257295
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.
    Adly AA, Ragab IA, Ismail EA, Farahat MM.
    Platelets; 2015 Aug 10; 26(7):645-50. PubMed ID: 25350586
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B, Maillot F, Ternant D, Passot C, Paintaud G, Bejan-Angoulvant T.
    J Pediatr; 2019 Jan 10; 204():225-233.e8. PubMed ID: 30314658
    [Abstract] [Full Text] [Related]

  • 36. Clinical outcome of childhood chronic immune thrombocytopenia: A 38-year experience from a single tertiary center in Thailand.
    Chotsampancharoen T, Sripornsawan P, Duangchoo S, Wongchanchailert M, McNeil E.
    Pediatr Blood Cancer; 2017 Nov 10; 64(11):. PubMed ID: 28453897
    [Abstract] [Full Text] [Related]

  • 37. Involvement of Fc gamma receptor polymorphism in the therapeutic response of idiopathic thrombocytopenic purpura.
    Fujimoto TT, Inoue M, Shimomura T, Fujimura K.
    Br J Haematol; 2001 Oct 10; 115(1):125-30. PubMed ID: 11722422
    [Abstract] [Full Text] [Related]

  • 38. Monoclonal antibodies that mimic the action of anti-D in the amelioration of murine ITP act by a mechanism distinct from that of IVIg.
    Song S, Crow AR, Siragam V, Freedman J, Lazarus AH.
    Blood; 2005 Feb 15; 105(4):1546-8. PubMed ID: 15479722
    [Abstract] [Full Text] [Related]

  • 39. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
    Neunert C, Heitink-Polle KMJ, Lambert MP.
    Br J Haematol; 2023 Oct 15; 203(1):17-22. PubMed ID: 37641973
    [Abstract] [Full Text] [Related]

  • 40. Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia.
    Wang SC, Yang KD, Lin CY, Huang AY, Hsiao CC, Lin MT, Tsai YG.
    Pediatr Blood Cancer; 2020 Feb 15; 67(2):e28075. PubMed ID: 31736241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.